Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

Inclusion Criteria

• •1. age 18-70 years; serum albumin level \<30 g/L;
• •2. estimated glomerular filtration rate (eGFR according to the CKD-EPI formula) ≥60 mL/min per 1.73 m2;
• •3. patients with a moderate risk of IMN and decline \<50% in proteinuria despite blockade of the renin-angiotensin system 3 months before randomization;
• •4. patients at high risk or very high risk of IMN.